OC-0279: A randomized phase II study testing for optimal strategy for patients with high risks rectal cancer. (April 2018) - Vuong, T.; Kavan, P.; Martin, A.G.; Azoulay, L.; Donath, D.; Lavoie, C.; Ferland, E.; Nguyen, N.; Vasilevsky, C.A.; Desgroseilliers, S.; Drolet, S.; Richard, C.; et al.